What did @krisdim_ifbbpro actually say?
The creator argues that glutathione is the one peptide you should take before anything else, claiming it will make NAD and MOTS-C "work that much better" by eliminating oxidative stress and removing toxins, including lead and other chemicals, from the body. That is a bold sequencing argument with some real science underneath it, and some serious problems on top.
A few things worth noting upfront: glutathione is not technically a peptide in the way BPC-157 or TB-500 are. It is a tripeptide, yes, but it is also an endogenous antioxidant your liver produces naturally. Calling it a peptide in the same breath as MOTS-C is a category-blurring move that matters when you are talking about mechanisms and expectations.
Does the science back this up?
Partially. The relationship between glutathione status and mitochondrial function is real and reasonably well-supported. The "detox toxins and lead" claim is where the science gets thin fast.
Glutathione does play a genuine role in cellular redox balance. Studies including Forman et al. (2009, Free Radical Biology and Medicine) have documented glutathione's role in neutralizing reactive oxygen species and supporting phase II detoxification pathways in the liver. There is also legitimate research showing that oxidative stress can blunt mitochondrial function, which is relevant to both NAD metabolism and MOTS-C signaling, which operates through the AMPK pathway (Lee et al., 2015, Cell Metabolism).
However, the idea that supplemental glutathione, especially oral glutathione, reliably raises tissue glutathione levels enough to produce these effects is contested. Oral bioavailability has historically been poor, though liposomal and sublingual forms show more promise (Richie et al., 2015, European Journal of Nutrition). IV glutathione bypasses that problem but introduces different considerations entirely.
What did they get wrong (or right)?
They got the general direction right: oxidative stress does interfere with mitochondrial signaling pathways, and glutathione is a real antioxidant with documented biology. Credit where it is due.
But "getting rid of the lead" is where this goes off the rails. Glutathione does participate in heavy metal conjugation through metallothionein-related pathways, but it is not a chelation agent in any clinical sense. The evidence for glutathione supplementation as a meaningful intervention for lead toxicity in humans is not there. Actual lead toxicity is a medical condition managed with agents like DMSA or EDTA under physician supervision, not a peptide stack you optimize around. Presenting it the way the creator does, as if glutathione is clearing your body of lead so your biohacking stack can function, is misleading and could give people false confidence that they have addressed a genuine toxicity problem.
The claim that NAD and MOTS-C will simply "work better" once glutathione is on board is also unverifiable. There are no human clinical trials testing that sequencing protocol.
What should you actually know?
If you are exploring glutathione, the delivery method matters more than most influencers admit. Oral supplementation has variable absorption. IV administration raises bioavailability substantially but is a clinical procedure. Precursors like N-acetylcysteine (NAC) have a stronger evidence base for raising intracellular glutathione than glutathione supplementation itself (Atkuri et al., 2007, Current Opinion in Pharmacology).
MOTS-C is a mitochondrial-derived peptide with genuinely interesting early research, mostly in animal models, around insulin sensitivity and aging (Kim et al., 2018, Aging). NAD precursors like NMN and NR have more human data but are still not fully characterized. Stacking these with glutathione based on a social media sequencing argument, rather than individual labs and physician oversight, is not a strategy supported by clinical evidence.
The creator does say "this is not medical advice" and tells viewers to consult a physician, which is the right instinct. But then they follow it with "message me to work peptide," which suggests a commercial relationship that viewers should factor into how they weigh the recommendation.